Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Red wine polyphenol extract is a mixture derived from the skins, seeds, and stems of red grapes (Vitis vinifera), standardized to contain high levels of polyphenolic compounds characteristic of red wine. Its main active constituents include flavanols (e.g., catechin, epicatechin), proanthocyanidins, flavonols (e.g., quercetin, myricetin), anthocyanins, and resveratrol. The extract exhibits potent antioxidant, anti-inflammatory, and cardioprotective properties. Mechanistically, it enhances endothelial nitric oxide synthase (eNOS) activity, increasing nitric oxide (NO) bioavailability, which contributes to improved vascular function and cardioprotection. Red wine polyphenol extract may also modulate kinase pathways (such as MAPK) and transcription factors (such as NFκB), resulting in anti-proliferative and anti-cancer effects. It is primarily investigated as a dietary supplement for cardiovascular health, metabolic syndrome, and as an adjunctive cancer-preventive agent[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on red wine polyphenol extract.